SCHEMBL5077185

SCHEMBL5077185

Nc1ncnn2c(-c3ccc(NC(=O)O)cc3)cc(-c3ccc4cn(Cc5ccccc5)nc4c3)c12

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 19/20 0.46
▸ AXL P30530 1/20 0.42
▸ MERTK Q12866 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14312723 0.94 RIPK1 (0.46) RIPK1
SCHEMBL14312842 0.89 RIPK1 (0.46) RIPK1
SCHEMBL5076719 0.88 ACVRL1 (0.42) RIPK1
SCHEMBL16496878 0.88 RIPK1 (0.43) RIPK1
SCHEMBL14312544 0.87 PIK3CD (0.43) RIPK1
SCHEMBL14313043 0.87 PIK3CD (0.52) RIPK1
SCHEMBL14312843 0.86 RIPK1 (0.43) RIPK1
SCHEMBL5141007 0.86 RIPK1 (0.46) RIPK1
SCHEMBL5077230 0.86 PIK3CD (0.47) RIPK1
SCHEMBL5076831 0.85 ACVRL1 (0.42) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945222-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer HealthCare AG (DE) 2008-07-23 — — EP disclosed
WO-2007056170-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2007-05-18 — — WO disclosed
Send feedback